Literature DB >> 33993770

Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.

Erin L Tomaszewski1, Trevor J Orchard1, Marquis S Hawkins1, Rebecca B N Conway2, Jeanine M Buchanich3, John Maynard4, Thomas Songer1, Tina Costacou1.   

Abstract

BACKGROUND: Skin intrinsic fluorescent (SIF) scores are indirect measures of advanced glycation end-products (AGEs). SIF scores are cross-sectionally associated with type 1 diabetes (T1D) complications such as increased albumin excretion rate (AER), coronary artery calcification (CAC) and neuropathy. We assessed predictors of SIF score change in those with T1D.
METHODS: Data from the 30-year longitudinal Epidemiology of Diabetes Complications (EDC) study of childhood-onset T1D were used to assess AGEs measured with a SIF score produced by the SCOUT DS® device. SIF scores were assessed twice in 83 participants: between 2007-08 and again between 2010-14. Regression analyses were used to assess independent predictors of SIF score change.
RESULTS: At baseline, mean age was 47.9 ± 6.9 years, diabetes duration was 36.7 ± 6.4 years, and median glycosylated hemoglobin (HbA1c) was 7.1 (interquartile range: 6.5, 8.5). During a mean follow-up of 5.2 ± 0.9 years, mean change in SIF score was 2.9 ± 2.8 arbitrary units. In multivariable linear regression models, log HbA1c (P < 0.001), log estimated glomerular filtration rate (eGFR) (P < 0.001), overt nephropathy (defined as AER ≥ 200 µg/min, P = 0.06), and multiple daily insulin shots/pump use (MDI) exposure years (P = 0.02) were independent predictors of SIF score change.
CONCLUSIONS: Increases in SIF score over 5 years were related to increased glycemic levels and decreased kidney function (eGFR). MDI and glomerular damage were related to a decreased SIF score. This is one of the first studies with repeated SIF assessments in T1D and provides unique, albeit preliminary, insight about these associations.

Entities:  

Keywords:  Epidemiology of Diabetes Complications study; advanced glycation end-products; complications; skin intrinsic fluorescence; type 1 diabetes

Mesh:

Substances:

Year:  2021        PMID: 33993770      PMCID: PMC8655295          DOI: 10.1177/19322968211014337

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  39 in total

Review 1.  Epidemiology of type 1 diabetes.

Authors:  David M Maahs; Nancy A West; Jean M Lawrence; Elizabeth J Mayer-Davis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

2.  Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.

Authors:  Kalina Rajaobelina; Catherine Helmer; Fritz-Line Vélayoudom-Céphise; Sovanndany Nov; Blandine Farges; Emilie Pupier; Laurence Blanco; Marie Hugo; Henri Gin; Vincent Rigalleau
Journal:  Diabetes Metab Res Rev       Date:  2017-09-05       Impact factor: 4.876

3.  Noninvasive, optical detection of diabetes: model studies with porcine skin.

Authors:  E Hull; M Ediger; A Unione; E Deemer; M Stroman; J Baynes
Journal:  Opt Express       Date:  2004-09-20       Impact factor: 3.894

4.  Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples.

Authors:  G R Warnick; J J Albers
Journal:  Clin Chem       Date:  1978-06       Impact factor: 8.327

5.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

6.  Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

Authors:  Patricia A Cleary; Barbara H Braffett; Trevor Orchard; Timothy J Lyons; John Maynard; Catherine Cowie; Rose A Gubitosi-Klug; Jeff Way; Karen Anderson; Annette Barnie; Stephan Villavicencio
Journal:  Diabetes Technol Ther       Date:  2013-06       Impact factor: 6.118

7.  Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II.

Authors:  T J Orchard; J S Dorman; R E Maser; D J Becker; A L Drash; D Ellis; R E LaPorte; L H Kuller
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

8.  Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes.

Authors:  Andries J Smit; Jitske M Smit; Gijs J Botterblom; Douwe J Mulder
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

9.  Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study.

Authors:  Mary A M Rogers; Catherine Kim; Tanima Banerjee; Joyce M Lee
Journal:  BMC Med       Date:  2017-11-08       Impact factor: 8.775

Review 10.  Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging.

Authors:  Maxime Fournet; Frédéric Bonté; Alexis Desmoulière
Journal:  Aging Dis       Date:  2018-10-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.